Meet our team

Stephen Pandol, M.D.

Co-Founder, Chief Medical Director

Professor of Medicine, UCLA; Director, Basic and Translational Pancreas Research, Cedars-Sinai Medical Center; President of the American Pancreatic Association from 2013-2014;  He is co-lead of the Consortium to Study Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Chief Editor for Frontiers in Gastrointestinal Sciences, past Associate Editor for the American Journal of Physiology, Author of over 500 publications, including The Exocrene Pancreas, and 8 patents. He led the research that resulted in Phyteau’s patents and medical approach to diabetes and obesity.  Dr. Pandol received the Lifetime Achievement Award from the American Pancreatic Association.

B.S. University of California, Davis;  M.D.  Saint Louis University Medical School

Bonn Macy

Co-Founder, CEO

Former management consultant with McKinsey & Co. and BoozAllen; 15+ years experience in Strategy, corporate planning, finance & economics; US Presidential appointee, 1997-2001. Founder & Director, Startup Santa Fe and Startup New Mexico.  Startup advisor and mentor.

B.S., M.S. Columbia University; M.Sc. London School of Economics

Hongxiang Hui, M.D., Ph.D.

Chief Operating Officer

Dr. Hui is an expert on metabolic diseases, oncology, wellness and longevity. He is Director and Professor of the International Metabolic Medicine Center at China Southern Medical University in Guangzhou and Associate Professor at the UCLA Medical School. ; He was also an early pioneer of GLP-1 research in China, studying the hormone for over 25 years.

Dr. Hui serves as Director and Officer on multiple medical organizations, and National institutions including, Medical Director, Nutrapas. Los Angeles; Medical Advisor, Proactiff Digital Healthcare Inc.; Director, Swiss Prestige International Medical Center, Guangzhou; Chief Scientific Officer, China Health Promotion Foundation, Beijing. He has published over 250 papers and has 13 patents on metabolism and cancer and is Associate Editor of Pancreas and of Frontiers in Gastrointestinal Science. and Executive Chairman of scientific advisory board of The Pacific-Asia Precision Medicine Forum.

Janine Lehmann

Co-Founder, Product Director

Co-Founder and Art Director, Trend Magazine for over 15 years.  Co-Founder, H-Haus, a sustainable, modern modular architecture startup.

Experience & expertise in operations, advertising, marketing and design.

B.A.  Hunter College, New York City

Pedro Tetteroo, Ph.D.


Former General Manager and VP, Centocor (Johnson & Johnson), the Netherlands. Pedro was instrumental is transforming Centocor from a start-up biotech company to a full commercial – FDA approved – production and supply chain organization, including acquisition by Johnson & Johnson. He was responsible for bringing the blockbuster drug, Remicade, to market.

Executive Coach, biotech startup mentor. Boards: Leiden Bio Science Park and Postdoc Career Development Initiative (Netherlands).

Ravinder Abrol, Ph.D.


Faculty, California State University, Northridge
Formerly, Cedars-Sinai Medical Center, Department of Medicine and Department of Biomedical Sciences; Director of Biomacromolecular
Simulations, Materials & Process Simulation Center at Caltech.

Editor, International Journal of Chemical Physics, and Journal of Biophysics; Assoc Editor, Frontiers in Physiology.

Expertise: Molecular Pharmacology, GPCR’s, Receptor Pharmacology, Molecular Mechanisms of Pharmacological Action.

Yuan-Ping Han, Ph.D.


Professor of Biochemistry, Molecular and Cell Biology, Sichuan University, Chengdu, China;
Visiting Faculty: Cedars-Sinai Medical Center.

Formerly, Faculty, USC Norris Comprehensive Cancer Center, Southern California Research Center for Alcoholic Liver and Pancreatic Diseases and USC Research Center for Liver Diseases, Keck School of Medicine at Univerity of Southern California.